Literature DB >> 6685059

Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator.

L Bányai, A Váradi, L Patthy.   

Abstract

Comparison of the primary structures of high-Mr urokinase and tissue-type plasminogen activator reveals a high degree of structural homology between the two proteins, except that tissue activator contains a 43 residue long amino-terminal region, which has no counterpart in urokinase. We show that this segment is homologous with the finger-domains responsible for the fibrin-affinity of fibronectin. Limited proteolysis of the amino-terminal region of plasminogen activator was found to lead to a loss of the fibrin-affinity of the enzyme. It is suggested that the finger-domains of fibronectin and tissue-types plasminogen activator have similar functions and that the finger-domains of the two proteins evolved from a common ancestral fibrin-binding domain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6685059     DOI: 10.1016/0014-5793(83)81157-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

1.  The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases.

Authors:  L Bányai; L Patthy
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

2.  Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin.

Authors:  A A Rostagno; J E Schwarzbauer; L I Gold
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

3.  Factor Xa-A pleuripotential protease.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

4.  Effector-assisted refolding of recombinant tissue-plasminogen activator produced in Escherichia coli.

Authors:  H Grunfeld; A Patel; A Shatzman; A H Nishikawa
Journal:  Appl Biochem Biotechnol       Date:  1992-05       Impact factor: 2.926

5.  Human tissue-type plasminogen activator gene located near chromosomal breakpoint in myeloproliferative disorder.

Authors:  T L Yang-Feng; G Opdenakker; G Volckaert; U Francke
Journal:  Am J Hum Genet       Date:  1986-07       Impact factor: 11.025

6.  Tissue-type plasminogen activator. Therapeutic potential in thrombotic disease states.

Authors:  D Collen
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

Review 7.  Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.

Authors:  R Fears
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

8.  Autonomous functions of structural domains on human tissue-type plasminogen activator.

Authors:  A J van Zonneveld; H Veerman; H Pannekoek
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 9.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

10.  The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.

Authors:  T Ny; F Elgh; B Lund
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.